Clinical Trial Update: Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a preemptive infusion of donor lymphocytes depleted of TCR+ T cells and CD19+ B cells after autologous stem cell transplantation has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Lymphoproliferative Disorders
• Myelodysplastic Syndrome
• Myeloproliferative Neoplasm

Snippet

Sponsor: Leland Metheny | Conditions: Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia | Phase 1 | Status: WITHDRAWN